OBI-1

modified recombinant Factor VIII · Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OBI-1, covering 2015-12-21 to 2015-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A [Phase 2, Phase 3]